Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients-Reference-Cited by-同舟云学术

Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients

Published:2010-12-15 Issue:11 Volume:90 Page:1215-1219
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Husain Shahid,Capitano Blair,Corcoran Timothy,Studer Sean M.,Crespo Maria,Johnson Bruce,Pilewski Joseph M.,Shutt Kathleen,Pakstis Diana L.,Zhang Shimin,Carey Mary Ellen,Paterson David L.,McCurry Kenneth R.,Venkataramanan Raman

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. Aspergillus airway colonization and invasive disease after lung transplantation.;Cahill;Chest,1997

2. Voriconazole prophylaxis in lung transplant recipients.;Husain;Am J Transplant,2006

3. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis.;Allen;J Antimicrob Chemother,1994

4. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial.;Schwartz;Blood,1999

5. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.;Drew;Transplantation,2004

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supramolecular hydrogels for sustained extracellular vesicle delivery;MRS Communications;2024-06-27

2. Application and evaluation of topical amphotericin B for the treatment of respiratory fungal infections;BMC Infectious Diseases;2024-04-24

3. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis;Journal of Fungi;2024-03-01

4. Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives;Nanomedicine;2024-01-25

5. Theranostic applications of nanoemulsions in pulmonary diseases;Design and Applications of Theranostic Nanomedicines;2023